Clorox (NYSE:CLX) Issues FY 2027 Earnings Guidance

Key Points

• Clorox guided FY 2027 adjusted EPS to $5.70–$6.00 and revenue to $7.6–$7.7 billion, broadly in line with analyst expectations, though management expects results toward the lower end of the EPS range.
• Clorox reported a strong quarterly performance, with EPS of $1.55 versus the $1.07 consensus and revenue of $1.91 billion, up 33.3% year over year and above estimates.
• Despite the earnings beat, inflation and higher input and operating costs remain concerns. Analysts maintain a cautious stance, with a consensus “Reduce” rating and a $93.29 target price; the company also declared a $1.25 quarterly dividend, yielding about 5.6%.

Clorox (NYSE:CLX - Get Free Report) updated its FY 2027 earnings guidance on Tuesday. The company provided EPS guidance of 5.700-6.000 for the period, compared to the consensus earnings per share estimate of 5.690. The company issued revenue guidance of $7.6 billion-$7.7 billion, compared to the consensus revenue estimate of $7.6 billion.

Wall Street Analysts Forecast Growth

Several research firms recently commented on CLX. JPMorgan Chase & Co. decreased their price objective on shares of Clorox from $95.00 to $83.00 and set an "underweight" rating on the stock in a research report on Monday, October 19th. Zacks Research cut Clorox from a "hold" rating to a "strong sell" rating in a report on Thursday, October 29th. Weiss Ratings reissued a "hold (c-)" rating on shares of Clorox in a research report on Tuesday, October 6th. The Goldman Sachs Group reissued a "sell" rating and issued a $74.00 price target on shares of Clorox in a report on Tuesday. Finally, Jefferies Financial Group downgraded Clorox from a "buy" rating to a "hold" rating and reduced their price objective for the company from $125.00 to $98.00 in a research report on Tuesday, July 28th. Twelve equities research analysts have rated the stock with a Hold rating and four have given a Sell rating to the company. According to MarketBeat.com, Clorox presently has a consensus rating of "Reduce" and a consensus target price of $93.29.

Clorox Stock Performance

Shares of CLX stock opened at $90.04 on Tuesday. The company has a debt-to-equity ratio of 15.80, a quick ratio of 0.38 and a current ratio of 0.66. The firm has a market capitalization of $10.89 billion, a price-to-earnings ratio of 18.68, a price-to-earnings-growth ratio of 2.91 and a beta of 0.59. Clorox has a one year low of $79.12 and a one year high of $128.90. The company has a 50 day moving average price of $88.27 and a 200 day moving average price of $99.92.

Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings results on Monday, November 2nd. The company reported $1.55 earnings per share for the quarter, beating analysts' consensus estimates of $1.07 by $0.48. Clorox had a net margin of 8.74% and a return on equity of 522.23%. The company had revenue of $1.91 billion for the quarter, compared to analyst estimates of $1.88 billion. During the same quarter last year, the business earned $0.85 EPS. Clorox's revenue for the quarter was up 33.3% on a year-over-year basis. Sell-side analysts anticipate that Clorox will post 5.66 EPS for the current year.

Clorox Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Wednesday, October 28th will be given a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a yield of 5.6%. The ex-dividend date of this dividend is Wednesday, October 28th. Clorox's dividend payout ratio is 103.73%.

Key Headlines Impacting Clorox

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: Clorox reported adjusted earnings of $1.55 per share, well above the $1.07 analyst consensus and up from $0.85 a year earlier. Revenue rose 33.3% year over year to $1.91 billion, exceeding estimates of $1.88 billion. Clorox Reports Q1 Fiscal Year 2027 Results
• Positive Sentiment: The earnings beat and better-than-expected sales are supporting investor sentiment, with management highlighting broad business momentum and improved profitability. Clorox Surpasses Q1 Earnings and Revenue Estimates
• Positive Sentiment: Evercore ISI upgraded Clorox from “underperform” to “in-line” and set a $99 price target, citing the incoming CEO’s turnaround experience as a potential catalyst for the earnings recovery. Evercore ISI Upgrades Clorox
• Neutral Sentiment: Management’s earnings call emphasized recovery efforts and operating priorities under the new CEO, but investors are likely to wait for evidence that the turnaround can produce sustainable growth. Clorox Q1 2027 Earnings Call Transcript
• Negative Sentiment: Clorox now expects full-year adjusted EPS toward the lower end of its previously issued $5.70–$6.00 range, tempering the impact of the quarterly beat. Clorox Posts Higher Revenue and Profit
• Negative Sentiment: Management cited inflation, higher input and other operating costs, and difficult comparisons created by prior-period distortions. These pressures could limit margin expansion despite strong reported sales and earnings. Clorox Guidance and Inflation Analysis

Clorox Company Profile

The Clorox Company, founded in 1913 and headquartered in Oakland, California, is a consumer and professional products company. It began with household bleach and has expanded into a portfolio of brands serving cleaning, household, personal care, food, and professional markets.

Its brands include Clorox disinfecting and cleaning products, Pine-Sol cleaners, Liquid-Plumr drain care, Kingsford charcoal, Fresh Step and Scoop Away cat litter, Hidden Valley dressings and dips, Brita water filtration products, and Burt's Bees personal care items.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.